Neda Alrawashdh

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Cross Sectional

Diffuse Large B Cell Lymphoma

Chemotherapy Induced

Top Venues

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Neda Alrawashdh, Jamie Vraney, Briana M Choi, Abdulaali R Almutairi, Ivo Abraham, Ali McBride
Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer. Future oncology (London, England) 18 (19) (2022)
Ali McBride, Neda Alrawashdh, Trace Bartels, Logan Moore, Daniel Persky, Ivo Abraham
Same-day versus next-day pegfilgrastim or pegfilgrastim-cbqv in patients with lymphoma receiving CHOP-like chemotherapy. Future oncology (London, England) 17 (26) (2021)
Ali McBride, Neda Alrawashdh, Karen M MacDonald, Ivo Abraham
Expanded access to anticancer treatments from conversion to biosimilar pegfilgrastim-cbqv in US breast cancer patients. Future oncology (London, England) (2021)
Karen M MacDonald, Neda Alrawashdh, Ali McBride, Ivo Abraham
Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer. Future oncology (London, England) 17 (33) (2021)